Plasmonic nanoparticle amyloid corona for screening Aβ oligomeric aggregate-degrading drugs
Effective screening of drugs to treat amyloid oligomeric aggregates associated with Alzheimer’s is needed for drug development. Here the authors report on the creation of an amyloid corona around a plasmonic nanoparticle to monitor amyloid degradation when exposed to potential drugs and demonstrate...
Guardado en:
Autores principales: | Dongtak Lee, Dongsung Park, Insu Kim, Sang Won Lee, Wonseok Lee, Kyo Seon Hwang, Jeong Hoon Lee, Gyudo Lee, Dae Sung Yoon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1bb9cb18a1fd4795883af0c9b3b04454 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The viral protein corona directs viral pathogenesis and amyloid aggregation
por: Kariem Ezzat, et al.
Publicado: (2019) -
Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
por: Pyun JM, et al.
Publicado: (2021) -
A generic mechanism of emergence of amyloid protofilaments from disordered oligomeric aggregates.
por: Stefan Auer, et al.
Publicado: (2008) -
Effects of Protein Corona on IAPP Amyloid Aggregation, Fibril Remodelling, and Cytotoxicity
por: Emily H. Pilkington, et al.
Publicado: (2017) -
Aminostyrylbenzofuran directly reduces oligomeric amyloid-β and reverses cognitive deficits in Alzheimer transgenic mice.
por: Sang-Hyun Lee, et al.
Publicado: (2014)